Literature DB >> 21696817

XMRV and CFS--the sad end of a story.

Frank J M van Kuppeveld1, Jos W M van der Meer.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21696817     DOI： 10.1016/S0140-6736(11)60899-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study.

Authors:  Graham Simmons; Simone A Glynn; Anthony L Komaroff; Judy A Mikovits; Leslie H Tobler; John Hackett; Ning Tang; William M Switzer; Walid Heneine; Indira K Hewlett; Jiangqin Zhao; Shyh-Ching Lo; Harvey J Alter; Jeffrey M Linnen; Kui Gao; John M Coffin; Mary F Kearney; Francis W Ruscetti; Max A Pfost; James Bethel; Steven Kleinman; Jerry A Holmberg; Michael P Busch
Journal:  Science       Date:  2011-09-22       Impact factor: 47.728

2.  Problems with precaution: the transfusion medicine experience.

Authors:  Kumanan Wilson; Katherine M Atkinson; Dean A Fergusson; Adalsteinn Brown; Alan Forster; Malia S Q Murphy; Alan T Tinmouth; Jennifer Keelan
Journal:  J Risk Res       Date:  2017-07-29

3.  The use of preliminary scientific evidence in public health: a case study of XMRV.

Authors:  Kumanan Wilson; Katherine Atkinson; Jennifer Keelan
Journal:  PLoS Med       Date:  2014-04-08       Impact factor: 11.069

4.  Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.

Authors:  Madlen Loebel; Kristin Strohschein; Carolin Giannini; Uwe Koelsch; Sandra Bauer; Cornelia Doebis; Sybill Thomas; Nadine Unterwalder; Volker von Baehr; Petra Reinke; Michael Knops; Leif G Hanitsch; Christian Meisel; Hans-Dieter Volk; Carmen Scheibenbogen
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

5.  Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment.

Authors:  Megan E Roerink; Hans Knoop; Ewald M Bronkhorst; Henk A Mouthaan; Luuk J A C Hawinkels; Leo A B Joosten; Jos W M van der Meer
Journal:  J Transl Med       Date:  2017-12-29       Impact factor: 5.531

6.  XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model?

Authors:  Kristin Stieler; Udo Schumacher; Andrea Kristina Horst; Nicole Fischer
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.